Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in CADL — Candel Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$648,291
+$485,122 QoQ
Shares Held
62,941
+89.0% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 138 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. CADL ranks #168 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in CADL

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $648,291 62,941
2026-03-31 $163,169 33,300
2025-12-31 $160,318 28,375
2025-09-30 $135,960 26,659
2025-06-30 $109,422 21,625
2025-03-31 $148,092 26,211
2024-12-31 $273,610 31,522
2024-09-30 $3,693 533
2024-06-30 $421 68